Enrichment analysis of all predicted drivers showed associations with cancer-related pathways, including Pathways in cancer, Proteoglycans in cancer, PI3K-Akt, MAPK, p53 signaling, platinum drug resistance, and multiple site-specific cancers (Figure 3C, Tables S4 and S5). Here, PIK3CA is linked to cancer.